Major Partnerships and Alliances

Peter Mac has multiple partnerships and collaborations with national and international organisations. We are also the first in Australia to partake in global collaborative network incentives focusing on immune-oncology with the aim to develop new treatments and therapies for cancer.

Immuno-oncology networks

  • Bristol-Myers Squibb II-ON – International Immuno-Oncology Network

    • Peter Mac is the first Australian institute to be added to BMS II-ON. II-ON is an international network of leading cancer-research institutions with focus on advancing immune-oncology for the treatment of cancer, through a series of preclinical, translational and biology-focused research objectives

                      Read the media release

  • Roche imCORE - Global Cancer Immunotherapy Centers of Research Excellence Network

    • imCORE is a global network of basic and clinical scientists from 21 leading academic research institutions in cancer immunotherapy. Roche and the network will work collaboratively and with Roche on new medicine, diagnostics and emerging data to accelerate new treatments in cancer research

  • GlaxoSmithKline OCTC – Oncology Clinical and Translational Consortium

    • A collaborative network to develop innovative patient therapies through rational combination and collaboration with external partners. Parties will share in GSKs early-stage oncology pipeline as well as share expertise in pre-clinical, translational and clinical development